 NEW YORK, Sept. 14, 2021 GLOBE NEWSWIRE -- SELLAS Life Sciences Group, Inc. NASDAQ: SLS SELLAS or the Company, a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today announced that Angelos Stergiou, MD, ScD. h.c., President and Chief Executive Officer of SELLAS, will present at the 2021 Cantor Global Healthcare Conference to be held virtually on Tuesday, September 28, 2021, at 4:00 p.m. ET. 